ARTICLE | Clinical News
Dacart: Phase III data
March 3, 2008 8:00 AM UTC
GlaxoSmithKline and partner Medicines for Malaria Venture discontinued development of Dacart to treat malaria after Phase III data showed that the compound significantly reduced hemoglobin levels in a...